Module 16 2024

21/10/2024

Legacy Device Scenario 1 – Cardiovascular Implant

• MDD CE certification based in clinical investigation performed • Ongoing registry of device implantation • Robust PMS process, trend analysis • Integrated processes: PMS, Risk management, CER and IFU

• PMCF Actions:

• Continue registry • Further clinical studies • Strengthen “generic” PMCF – monitor SOTA, literature review

© NAMSA 2023 | 19

19

Legacy Device Scenario 2 – Surgical Instrument

• MDD CE certification based in equivalence • Additional literature multiple single patient case studies • PMS well performed and data robust • No PMCF activity • Not all claims made supported by robust evidence • WET

• PMCF Actions:

• Implement Survey (preferably in EU) • Strengthen “generic” PMCF – monitor SOTA, literature review

© NAMSA 2023 | 20

20

10